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EDITORIAL
Evidence based medicine reviews
In this issue we reintroduce the Evidence Based
Reviews Section. This feature is aimed at updating
clinicians and researchers about the management
of respiratory disease. Some of the articles pub-
lished in this section will be individual systematic
reviews. Others will be linked overviews that
summarise the results of a number of reviews
dealing with related interventions for a particular
disease. Reviews that have already been published
in this section of the journal have included breath-
ing retraining for asthma,1 spacers and nebulisers
for the delivery of beta-agonists in acute asthma,2
antibiotics in the management of non-CF bronch-
iectasis,3 asthma education,3 NIPPV in chronic
obstructive pulmonary disease4 and cardioselective
beta-blockers in COPD.5
In contrast to the more familiar narrative re-
views, systematic reviews attempt to minimise bias
in the literature review process by applying a strict
and objective process to the analysis of the
available evidence. Where it is possible and
appropriate to combine the data, this leads to a
more reliable estimate of the average effect of a
treatment. Because the trial evidence is laid out
clearly the reader can inspect this for themselves.
How the reviewers arrived at their conclusions
should also be clear to the reader. Interested
readers are encouraged to read the comprehensive
introduction to the aims and methodology of
systematic reviews by Paul Jones, who was the
inaugural editor of this section.6
In 2003, Mike Clarke, co-chair of the steering
group of the Cochrane Collaboration estimated that
10,000 systematic reviews were required to cover
the range of health care interventions that have
been studied in controlled clinical trials.7 Cur-
rently, the collaboration lists about 3000 reviews
that are either completed or underway. Clearly
there is still considerable scope for the develop-
ment of systematic reviews of therapy.
Overviews of systematic reviews are useful too.
At the most practical level they provide a succinct
summary for the busy clinician of the systematic
review evidence for related interventions for
particular diseases. By identifying the existing
systematic reviews, they allow the clinician to go
back to these if desired, to themselves evaluate the
strength of evidence for particular interventions.
The overviews may indicate where more clinical
trials and/or systematic reviews are required. They
also allow an examination of the methodology as
part of a critical appraisal of the systematic
reviews.
The first two publications in 2004 in the
Evidence-Based Reviews section are overviews of
systematic reviews, although they are quite differ-
ent in approach. In this issue the use of corticos-
teroids in acute exacerbations of asthma is
explored by looking at a number of systematic
reviews on this topic.8 These reviews address the
evidence for different doses, routes, timing and
duration of corticosteroid therapy. In May, an
overview of the systematic reviews of low mole-
cular weight heparin (LMWH) versus unfractionated
heparin (UFH) for the treatment of venous throm-
boembolic disease (VTE) will be published.9 This
shows how the average effect size for treatment
with LMWH has changed as more studies have been
included in the reviews.
We will continue to commission material for this
section but we are also prepared to receive
unsolicited systematic reviews or overviews that
have not previously published, provided they con-
form to the aims of this section and have been
developed using the appropriate methodology.
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